ICFP News & Insights

Medicines360: Creating Equitable Access

Nov 11, 2022

GUEST COLUMN:

Medicines360

by Tina Raine-Bennett

Our Mission is to catalyze equitable access to medicines and devices through product development, policy advocacy, and collaboration with global and U.S. partners

We are expanding access to our IUD in Africa, South and Southeast Asia, Central America, and the Caribbean, under the brand AvibelaTM

AVIBELA is manufactured in Belgium and supplied to global and local partners by Medicines360

Local partners lead distribution, training, and service delivery
AVIBELA is available at a subsidized access price for all units ordered through international procurement group catalogs or on behalf of eligible public sector programs.

For questions or to learn more about Avibela and about the new products and partnerships in our pipeline, visit Avibela.com, Medicines360.org, or email globalaccess@medicines360.org

 

Learn more about the Medicines360:

Explore More

Why Sexual Reproductive Health and Rights is a Social Justice Issue and What We Must Do About It

Why Sexual Reproductive Health and Rights is a Social Justice Issue and What We Must Do About It

The ICFP 2025 Impact Hub is Here

The ICFP 2025 Impact Hub is Here

From Bogotá to Global Impact: The ICFP Impact Hub Launch

From Bogotá to Global Impact: The ICFP Impact Hub Launch

No results found.